NEWAMSTERDAM PHARMA COMPANY (NAMSW) Institutional Ownership and Insiders Activity

NEWAMSTERDAM PHARMA COMPANY (NAMSW) is widely held by institutional investors, with 189 firms reporting positions valued at approximately $4.09B based on SEC Form 13F filings for the quarter ended June 30, 2026.

Frazier Life Sciences Management, L.P. is the largest disclosed holder, reporting approximately $613.03M in NAMSW holdings in its latest filing.